Copyright Reports & Markets. All rights reserved.

Global Gene Expression and Transcriptome Sequencing Market Growth (Status and Outlook) 2023-2029

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Gene Expression and Transcriptome Sequencing Market Size 2018-2029
    • 2.1.2 Gene Expression and Transcriptome Sequencing Market Size CAGR by Region 2018 VS 2022 VS 2029
  • 2.2 Gene Expression and Transcriptome Sequencing Segment by Type
    • 2.2.1 Gene Expression
    • 2.2.2 Transcriptome Sequencing
  • 2.3 Gene Expression and Transcriptome Sequencing Market Size by Type
    • 2.3.1 Gene Expression and Transcriptome Sequencing Market Size CAGR by Type (2018 VS 2022 VS 2029)
    • 2.3.2 Global Gene Expression and Transcriptome Sequencing Market Size Market Share by Type (2018-2023)
  • 2.4 Gene Expression and Transcriptome Sequencing Segment by Application
    • 2.4.1 Pharmaceutical and Biotechnology
    • 2.4.2 Academic Research and Government Institutes
    • 2.4.3 Hospitals and Diagnostic Centers
  • 2.5 Gene Expression and Transcriptome Sequencing Market Size by Application
    • 2.5.1 Gene Expression and Transcriptome Sequencing Market Size CAGR by Application (2018 VS 2022 VS 2029)
    • 2.5.2 Global Gene Expression and Transcriptome Sequencing Market Size Market Share by Application (2018-2023)

3 Gene Expression and Transcriptome Sequencing Market Size by Player

  • 3.1 Gene Expression and Transcriptome Sequencing Market Size Market Share by Players
    • 3.1.1 Global Gene Expression and Transcriptome Sequencing Revenue by Players (2018-2023)
    • 3.1.2 Global Gene Expression and Transcriptome Sequencing Revenue Market Share by Players (2018-2023)
  • 3.2 Global Gene Expression and Transcriptome Sequencing Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Gene Expression and Transcriptome Sequencing by Regions

  • 4.1 Gene Expression and Transcriptome Sequencing Market Size by Regions (2018-2023)
  • 4.2 Americas Gene Expression and Transcriptome Sequencing Market Size Growth (2018-2023)
  • 4.3 APAC Gene Expression and Transcriptome Sequencing Market Size Growth (2018-2023)
  • 4.4 Europe Gene Expression and Transcriptome Sequencing Market Size Growth (2018-2023)
  • 4.5 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Size Growth (2018-2023)

5 Americas

  • 5.1 Americas Gene Expression and Transcriptome Sequencing Market Size by Country (2018-2023)
  • 5.2 Americas Gene Expression and Transcriptome Sequencing Market Size by Type (2018-2023)
  • 5.3 Americas Gene Expression and Transcriptome Sequencing Market Size by Application (2018-2023)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Gene Expression and Transcriptome Sequencing Market Size by Region (2018-2023)
  • 6.2 APAC Gene Expression and Transcriptome Sequencing Market Size by Type (2018-2023)
  • 6.3 APAC Gene Expression and Transcriptome Sequencing Market Size by Application (2018-2023)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Gene Expression and Transcriptome Sequencing by Country (2018-2023)
  • 7.2 Europe Gene Expression and Transcriptome Sequencing Market Size by Type (2018-2023)
  • 7.3 Europe Gene Expression and Transcriptome Sequencing Market Size by Application (2018-2023)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Gene Expression and Transcriptome Sequencing by Region (2018-2023)
  • 8.2 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Size by Type (2018-2023)
  • 8.3 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Size by Application (2018-2023)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Gene Expression and Transcriptome Sequencing Market Forecast

  • 10.1 Global Gene Expression and Transcriptome Sequencing Forecast by Regions (2024-2029)
    • 10.1.1 Global Gene Expression and Transcriptome Sequencing Forecast by Regions (2024-2029)
    • 10.1.2 Americas Gene Expression and Transcriptome Sequencing Forecast
    • 10.1.3 APAC Gene Expression and Transcriptome Sequencing Forecast
    • 10.1.4 Europe Gene Expression and Transcriptome Sequencing Forecast
    • 10.1.5 Middle East & Africa Gene Expression and Transcriptome Sequencing Forecast
  • 10.2 Americas Gene Expression and Transcriptome Sequencing Forecast by Country (2024-2029)
    • 10.2.1 United States Gene Expression and Transcriptome Sequencing Market Forecast
    • 10.2.2 Canada Gene Expression and Transcriptome Sequencing Market Forecast
    • 10.2.3 Mexico Gene Expression and Transcriptome Sequencing Market Forecast
    • 10.2.4 Brazil Gene Expression and Transcriptome Sequencing Market Forecast
  • 10.3 APAC Gene Expression and Transcriptome Sequencing Forecast by Region (2024-2029)
    • 10.3.1 China Gene Expression and Transcriptome Sequencing Market Forecast
    • 10.3.2 Japan Gene Expression and Transcriptome Sequencing Market Forecast
    • 10.3.3 Korea Gene Expression and Transcriptome Sequencing Market Forecast
    • 10.3.4 Southeast Asia Gene Expression and Transcriptome Sequencing Market Forecast
    • 10.3.5 India Gene Expression and Transcriptome Sequencing Market Forecast
    • 10.3.6 Australia Gene Expression and Transcriptome Sequencing Market Forecast
  • 10.4 Europe Gene Expression and Transcriptome Sequencing Forecast by Country (2024-2029)
    • 10.4.1 Germany Gene Expression and Transcriptome Sequencing Market Forecast
    • 10.4.2 France Gene Expression and Transcriptome Sequencing Market Forecast
    • 10.4.3 UK Gene Expression and Transcriptome Sequencing Market Forecast
    • 10.4.4 Italy Gene Expression and Transcriptome Sequencing Market Forecast
    • 10.4.5 Russia Gene Expression and Transcriptome Sequencing Market Forecast
  • 10.5 Middle East & Africa Gene Expression and Transcriptome Sequencing Forecast by Region (2024-2029)
    • 10.5.1 Egypt Gene Expression and Transcriptome Sequencing Market Forecast
    • 10.5.2 South Africa Gene Expression and Transcriptome Sequencing Market Forecast
    • 10.5.3 Israel Gene Expression and Transcriptome Sequencing Market Forecast
    • 10.5.4 Turkey Gene Expression and Transcriptome Sequencing Market Forecast
    • 10.5.5 GCC Countries Gene Expression and Transcriptome Sequencing Market Forecast
  • 10.6 Global Gene Expression and Transcriptome Sequencing Forecast by Type (2024-2029)
  • 10.7 Global Gene Expression and Transcriptome Sequencing Forecast by Application (2024-2029)

11 Key Players Analysis

  • 11.1 Thermo Fisher Scientific
    • 11.1.1 Thermo Fisher Scientific Company Information
    • 11.1.2 Thermo Fisher Scientific Gene Expression and Transcriptome Sequencing Product Offered
    • 11.1.3 Thermo Fisher Scientific Gene Expression and Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
    • 11.1.4 Thermo Fisher Scientific Main Business Overview
    • 11.1.5 Thermo Fisher Scientific Latest Developments
  • 11.2 Illumina
    • 11.2.1 Illumina Company Information
    • 11.2.2 Illumina Gene Expression and Transcriptome Sequencing Product Offered
    • 11.2.3 Illumina Gene Expression and Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
    • 11.2.4 Illumina Main Business Overview
    • 11.2.5 Illumina Latest Developments
  • 11.3 QIAGEN (Exiqon)
    • 11.3.1 QIAGEN (Exiqon) Company Information
    • 11.3.2 QIAGEN (Exiqon) Gene Expression and Transcriptome Sequencing Product Offered
    • 11.3.3 QIAGEN (Exiqon) Gene Expression and Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
    • 11.3.4 QIAGEN (Exiqon) Main Business Overview
    • 11.3.5 QIAGEN (Exiqon) Latest Developments
  • 11.4 Agilent Technologies
    • 11.4.1 Agilent Technologies Company Information
    • 11.4.2 Agilent Technologies Gene Expression and Transcriptome Sequencing Product Offered
    • 11.4.3 Agilent Technologies Gene Expression and Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
    • 11.4.4 Agilent Technologies Main Business Overview
    • 11.4.5 Agilent Technologies Latest Developments
  • 11.5 Roche
    • 11.5.1 Roche Company Information
    • 11.5.2 Roche Gene Expression and Transcriptome Sequencing Product Offered
    • 11.5.3 Roche Gene Expression and Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
    • 11.5.4 Roche Main Business Overview
    • 11.5.5 Roche Latest Developments
  • 11.6 GE Healthcare
    • 11.6.1 GE Healthcare Company Information
    • 11.6.2 GE Healthcare Gene Expression and Transcriptome Sequencing Product Offered
    • 11.6.3 GE Healthcare Gene Expression and Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
    • 11.6.4 GE Healthcare Main Business Overview
    • 11.6.5 GE Healthcare Latest Developments
  • 11.7 Bio-Rad Laboratories
    • 11.7.1 Bio-Rad Laboratories Company Information
    • 11.7.2 Bio-Rad Laboratories Gene Expression and Transcriptome Sequencing Product Offered
    • 11.7.3 Bio-Rad Laboratories Gene Expression and Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
    • 11.7.4 Bio-Rad Laboratories Main Business Overview
    • 11.7.5 Bio-Rad Laboratories Latest Developments
  • 11.8 Fluidigm
    • 11.8.1 Fluidigm Company Information
    • 11.8.2 Fluidigm Gene Expression and Transcriptome Sequencing Product Offered
    • 11.8.3 Fluidigm Gene Expression and Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
    • 11.8.4 Fluidigm Main Business Overview
    • 11.8.5 Fluidigm Latest Developments

12 Research Findings and Conclusion

The global Gene Expression and Transcriptome Sequencing market size is projected to grow from US$ 4034.3 million in 2022 to US$ 9260.8 million in 2029; it is expected to grow at a CAGR of 12.6% from 2023 to 2029.

United States market for Gene Expression and Transcriptome Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Gene Expression and Transcriptome Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Gene Expression and Transcriptome Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Gene Expression and Transcriptome Sequencing players cover Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories and Fluidigm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Gene expression refers to the process by which information encoded in a gene is used to create functional gene products, such as proteins or non-coding RNAs. It involves the transcription of DNA into RNA and the subsequent translation of RNA into proteins. Gene expression is a fundamental process that plays a crucial role in various biological processes, including development, growth, and maintenance of tissues, as well as response to environmental stimuli.

LPI (LP Information)' newest research report, the “Gene Expression and Transcriptome Sequencing Industry Forecast” looks at past sales and reviews total world Gene Expression and Transcriptome Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Expression and Transcriptome Sequencing sales for 2023 through 2029. With Gene Expression and Transcriptome Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Expression and Transcriptome Sequencing industry.

This Insight Report provides a comprehensive analysis of the global Gene Expression and Transcriptome Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Expression and Transcriptome Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Expression and Transcriptome Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Expression and Transcriptome Sequencing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Expression and Transcriptome Sequencing.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Expression and Transcriptome Sequencing market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
Gene Expression
Transcriptome Sequencing

Segmentation by application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm

Buy now